Central 5-HT₃ Receptor Stimulation by m-CPBG Increases Blood Glucose in Rats

Abstract

The aim of the present study was to investigate the role of central 5-HT₃ receptors on the control of blood glucose in stressed and non-stressed rats in both fasted and fed states. Adult Wistar male rats had each their third ventricle cannulated 7 days before the experiments. Injections of m-CPBG, a selective 5-HT₃ receptor agonist, induced a significant increase in blood glucose in non-stressed rats in both fasted and in fed states. The same procedure was unable to modify stress-induced hyperglycemia. The hyperglycemic effect of m-CPBG central administration was blocked by pretreatment with ondansetron, a specific 5-HT₃ receptor antagonist, indicating that the effects here obtained with m-CPBG were a result of its interaction with 5-HT₃ receptors. Third ventricle injections of ondansetron alone were not able to modify blood glucose in non-stressed animals and did not change the hyperglycemic responses observed after immobilization stress. We conclude that pharmacological activation of the central 5-HT₃ receptor induces a hyperglycemic effect in non-stressed animals.

Key words

Serotonin - Stress - Blood Glucose - Hyperglycemia - 5-HT₃ Receptor

References

• 1 Chaouloff F, Jeanrenaud B. 5-HT_1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino) tetralin in conscious rat.  J Pharmacol Exp Ther. 1987;  243 1159-1166
• 2 Chaouloff F, Laude D, Baudrie V. Effects of the 5-HT_1C/5-HT₂ receptor agonists DOI and α-methyl-5-HT on plasma glucose and insulin levels in the rat.  Eur J Pharmacol. 1990;  187 435-443
• 3 Chaouloff F, Gunn S H, Young J B. Central 5-hydroxytryptamine₂ receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat.  J Pharmacol Exp Ther. 1992;  260 1008-1016
• 4 Durcan M J, Wozniak K M, Linnoila M. Modulation of the hypothermia and hyperglycaemic effects of 8-OH-DPAT by α2-adrenoceptor antagonists.  Br J Pharmacol. 1991;  102 222-226
• 5 Sugimoto Y, Yamada J, Yoshikawa T, Horisaka K. Effects of the 5-HT_2B/2C receptor agonist l-(3-chlorophenyl)piperazine on the plasma glucose levels of rats.  Eur J Pharmacol. 1996;  307 75-80
• 6 Yamada J, Sugimoto Y, Yoshikawa T. p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT_1A and 5-HT_2B/2C receptors.  Eur J Pharmacol. 1998;  359 185-190
• 7 Luiten P GM, Ter Horst G J, Steffens A B. The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism.  Prog Neurobiol. 1987;  28 1-54
• 8 Wozniak K M, Linnoila M. Hyperglycemic properties of serotonin receptor antagonists.  Life Sci. 1991;  49 101-109
• 9 Korte S M, van Duin S, Bouws G A, Koolhaas J M, Bohus B. Involvement of hypothalamic serotonin in activation of the sympathoadrenomedullary system and hypothalamo-pituitary-adrenocortical axis in male Wistar rats.  Eur J Pharmacol. 1991;  197 225-228
• 10 Chaouloff F, Laude D, Baudrie V. Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT.  Eur J Pharmacol. 1990;  185 11-18
• 11 Chrousos G P, Gold P W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.  J Am Med Assoc. 1992;  267 1244-1252
• 12 Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems.  Brain Res Rev. 1993;  18 1-32
• 13 Harms P G, Ojeda S R. A rapid and simple procedure for chronic cannulation of rat jugular vein.  J Appl Physiol. 1974;  36 391-394
• 14 Kilpatrick G J, Butler A, Burridge J, Oxford A W. l-(m-Chlorophenyl)-biguanide, a potent high affinity 5-HT₃ receptor agonist.  Eur J Pharmacol. 1990;  182 193-197
• 15 Gaster L M, King F D. Serotonin 5-HT₃ and 5-HT₄ receptor antagonists.  Med Res Rev. 1997;  17 163-214
• 16 Yamada J, Sugimoto Y, Inoue K. Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms.  Eur J Pharmacol. 1999;  382 211-215
• 17 Nonogaki K, Iguchi A. Role of central neural mechanisms in the regulation of hepatic glucose metabolism.  Life Sci. 1997;  60 797-807
• 18 Shimazu T, Fukuda A, Ban T. Reciprocal influences of the ventromedial and lateral hypothalamic nuclei on blood glucose level and liver glycogen content.  Nature. 1966;  210 1178-1179
• 19 Iguchi A, Kunoh Y, Miura H, Uemura K, Yatomi A, Tamagawa T, Kawahara H, Sakamoto N. Central nervous system control of glycogenolysis and gluneogenesis in fed and fasted rat liver.  Metabolism. 1989;  38 1216-1221
• 20 Baudrie T, Chaouloff F. Mechanisms involved in the hyperglycemic effect of the 5-HT_1C/5-HT₂ receptor agonist DOI.  Eur J Pharmacol. 1992;  213 41-46
• 21 Bloom F E, Morales M. The central 5-HT₃ receptor in CNS disorders.  Neurochem Res. 1998;  23 653-659
• 22 Peters J, Lambert J. Electrophysiology of 5-HT₃ receptors in neuronal cell lines.  Trends Pharmacol Sci. 1989;  10 172-174
• 23 Nonogaki K, Iguchi A. Role of central neural mechanisms in the regulation of hepatic glucose metabolism.  Life Sci. 1997;  60 797-807
• 24 Diez-Ariza M, Ramirez M J, Lasheras B, Del Rio J. Differential interaction between 5-HT₃ receptors and GABAergic neurons inhibiting acetylcholine release in rat enthorhinal cortex slices.  Brain Res. 1998;  801 228-232
• 25 Bames J M, Barnes N M, Costall B, Naylor R J, Tyers M B. 5-HT₃ receptors mediate inhibition of acetylcholine release in cortical tissue.  Nature. 1989;  338 762-763
• 26 Jansen A S, Nguyen X V, Karpitskiy V, Mettenleiter T C, Loewy A D. Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response.  Science. 1995;  270 644-646
• 27 Chaouloff F, Berton O, Mormede P. Serotonin and stress.  Neuropsychopharmacol. 1999;  21 28S-32S
• 28 Badgy G, Calogero A E, Murphy D, Szemeredi K. Serotonin agonists cause parallel activation of sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.  Endocrinol. 1989;  165 2664-2669
• 29 Doherty K M. Closing the gap in prophylactic antiemetic therapy: patient factors in calculating the emetogenic potential of chemotherapy.  Clin J Oncol Nurs. 1999;  3 113-119